コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 -4-CLP36 complex in podocytes and provide an explanation as to how alpha-actinin-4 deficiency or muta
2 he HIV capsid in nuclear entry and offers an explanation as to how an exogenous entity much larger th
3 ace of the T3 channel, providing a plausible explanation as to how BCL9 co-factors binding to Pygo PH
5 ivity and might begin to provide a molecular explanation as to how E2 modulates dendritic spine plast
6 l transcriptomic vulnerability, providing an explanation as to how heterogenous pathological entities
8 rogen bonding in the active site suggests an explanation as to how in the wild-type and H98N mutated
10 by membrane lipid composition, providing an explanation as to how its membrane-stressing activity is
11 s of intracellular Na+ and hence provides an explanation as to how KNa channel can control normal neu
15 experimental evidence for its presence or an explanation as to how such a polar molecule could exit t
16 methylation in cis and provide a mechanistic explanation as to how these loci impact upon OA suscepti
17 ing pathway, and provide a first mechanistic explanation as to how upregulation of CD44 may constitut
19 stal structures and, in many cases, detailed explanations as to how and why organisms synthesis and m
20 for clinical application, allowing for clear explanations as to how the predictions are produced, how
21 tion domains, our results provide a possible explanation as to the reason that RUNX1 is recurrently f
23 A processing and 60S generation and offer an explanation as to why a subtle dysfunction of BCCIP can
25 dy to cause pathogenicity and may provide an explanation as to why apparently similar auto-antibodies
26 p53 to maintain hepatic CSCs and provide an explanation as to why autophagy is required to promote h
27 ipose tissue and also represents a plausible explanation as to why brown adipocytes ultimately specia
33 ng the optic nerves, could be an alternative explanation as to why glaucoma develops in patients with
35 W loci in (NZB x NZW)F1 mice and provides an explanation as to why H2(d/z) heterozygosity is required
39 f Slc30a8 deletion, though the physiological explanation as to why impaired insulin secretion is not
40 ith that of a group, and is the current best explanation as to why individuals become empowered to ac
42 l expansion of this population, providing an explanation as to why Mir155 deletion impairs affinity m
43 ery common, but to date there is no complete explanation as to why one out of two people systematical
45 une evasion of PR-positive tumors may be one explanation as to why over 65% of breast cancers are PR
46 urthermore, our findings provide a plausible explanation as to why P[6] RV strains are more common in
48 during physical therapy provides a potential explanation as to why physical therapy may often be inef
54 tractility, and ECM stiffness and provide an explanation as to why stiffer environments result in enh
56 of the R(61,2)C adduct provides a potential explanation as to why that adduct does not induce A -->
59 vivo, and they provide a potential molecular explanation as to why the developmental impact of these
61 perimental regioselectivities and provide an explanation as to why the hydrogen is transferred from t
63 eported high-resolution structure provide an explanation as to why the mutation reduces ATP sensitivi
64 y Hsp70/40 chaperones, providing a molecular explanation as to why the N domain is dispensable for pr
68 ural communication signals, but also a novel explanation as to why these preferentially occur on top
69 heir bacterial homologues, thus providing an explanation as to why this novel chloroplast SRP pathway
70 mine transporter, and provides an intriguing explanation as to why use of these compounds, unlike coc
72 of myelin to CNS plasticity provide possible explanations as to why almost all patients with hypomyel
74 These experimental results offer possible explanations as to why Juliette is perceived to have a s
75 g merlin, Falco columbarius, and alternative explanations as to why observed behaviours should differ
77 d the acquisition/loss of mutations, to give explanations as to why there is a discrepancy in pharmac